Bayer Accelerates Grants4Apps Accelerator Program
Bayer’s Grants4Apps: An accelerator run by a pharma company | mobihealthnews
My “Ice Bucket” Challenge: Donate to a Different Cause to Improve the Health &...
This weekend, Thibaud Guymard (@thibaudguymard), Digital Marketing Manager at MSD France, nominated me (and a few others) to take the ALS "Ice Bucket Challenge."...
Drug Industry Rips Into FDA Over Social Media Guidelines: Twitter & Google Adwords
This article summarizes some of the main points made by PhRMA, Washington Legal Foundation (WLF), BIO, Medical Information Working Group (MIWG), Patient, Consumer, and Public Health Coalition, and several pharmaceutical companies, regarding FDA's Draft Guidance on using Internet and social media platforms with character space limitations.
More FDA Guidance on Distribution of Reprints: Presenting “New Risk Information” About Drugs
This reviews FDA's recommendations for distributing reprints that convey 'new risk information' for approved drugs.
Online e-Patient & Celebrity Patient Video Testimonials: Anecdotal Experience Marketing
This article asks the question: Can anecdotal 'evidence'/experiences mentioned in patient videos -- even unbranded videos -- cause unnecessary visits to the doctor's office and over prescribing of drugs with serious side effects?
Pharma Marketing News Vol. 13, No. 8: September 2014
Welcome to Volume 13, Issue #8 (SEPTEMBER 2014) of Pharma Marketing News.
Mobile App Usage Surges. Will Pharma Ads Follow?
According to the 2014 U.S. Mobile App Report by Comscore, U.S. digital consumers now spend more time using mobile apps than they do on...
FDA’s “Off-Label Risk Reduction” Approach to Reprint Distribution is “Misguided,” Says Sidney Wolfe
In June, the FDA issued a THIRD draft guidance document regarding reprint distribution by pharmaceutic companies. This new guidance describes FDA’s recommendations for distributing...
FDA Targets Companies for Facebook ‘Likes.’ Is Twitter ‘Favorites’ Next?
FDA Targets Companies for Facebook 'Likes.' Is Twitter 'Favorites' Next?
Why I Will Be Attending Digital Pharma East
Rich Meyer initiated quite a controversy on his World of DTC Marketing blog when he posted a "guest" article by an anonymous "Senior Director...
